Skip to main content
NVDA+0.02%AAPL-0.06%GOOGL+1.55%MSFT-0.07%AMZN+0.24%TSM+2.41%SPCX-0.56%META-0.07%AVGO+1.41%TSLA+0.07%SKHY+0.73%MU+0.08%LLY+1.00%BRK-B-1.52%AMD+9.95%JPM+0.68%WMT+0.67%V+0.45%XOM-3.20%ASMLa+2.45%JNJ-0.19%INTC+12.14%0700.HK+4.58%MA+0.43%ABBV+0.20%1398.HK-1.09%CSCO+1.78%ORCL+0.64%BAC+0.40%CVX-2.73%COST+0.35%DELL+1.26%LRCX+4.92%CAT+0.93%KO-1.28%AMAT+4.42%AP2d+5.60%0005.HK-0.10%HSBA.L+1.40%PG-0.19%ARM+17.16%UNH+0.18%GE+1.51%3988.HK-0.45%MS+1.75%1816.HK-30.02%NFLX+2.19%0939.HK-0.28%HD-0.93%0857.HK-0.63%NZDJPY+0.84%CHFJPY+0.63%NZDCAD+0.62%EURNZD-0.57%NZDMXN+0.53%USDJPY+0.50%GBPNZD-0.49%NZDSGD+0.43%AUDNZD-0.43%CADCHF-0.42%GBPTRY+0.41%AUDJPY+0.39%GBPJPY+0.32%EURCHF-0.32%GBPHKD+0.32%NZDUSD+0.31%NOKJPY+0.30%USDCAD+0.30%GBPCHF-0.29%GBPMXN-0.28%EURJPY+0.27%NZDCHF+0.23%EURUSD-0.22%AUDCHF-0.22%GBPZAR+0.19%SGDJPY+0.19%CADJPY+0.19%AUDCAD+0.19%USDZAR+0.18%GBPUSD-0.18%AUDNOK-0.18%EURZAR+0.16%USDILS+0.16%USDTHB-0.16%EURNOK-0.16%GBPCAD+0.13%CHFNOK-0.13%USDCHF-0.12%USDNOK-0.12%USDTRY+0.11%AUDUSD-0.11%USDPLN+0.09%EURAUD-0.09%USDMXN+0.09%PLNJPY+0.09%EURHKD-0.07%AUDSGD-0.07%GBPAUD-0.06%EURPLN+0.06%EURCNH+0.05%EURSGD-0.05%EURCZK+0.05%EURCAD+0.05%USDCOP-0.04%EURGBP-0.03%USDDKK+0.03%CHFSGD-0.03%USDHKD-0.03%EURSEK-0.02%USDCNH+0.02%USDSGD-0.02%AUDDKK-0.02%USDSEK+0.01%GBPSGD-0.01%EURDKK0.00%CHFSEK0.00%USOIL+1.53%UKOIL+1.51%XNGUSD+1.17%GAGUSD-1.10%XAGUSD-1.10%XPTUSD-1.10%XAUUSD-0.55%GAUUSD-0.55%COTTON-0.37%HG1+0.28%W1-0.17%S1-0.10%BTCUSD+5.32%ETHUSD+3.39%USDTUSD-0.04%XRPUSD+7.96%SOLUSD+4.89%TRXUSDT+1.93%ZECUSDT-0.42%DOGEUSD+14.65%XMRUSDT+2.69%LINKUSD+3.51%XLMUSD+7.81%UNIUSD+2.18%BCHUSDT+5.01%LTCUSD+3.89%HBARUSDT+7.44%SUIUSD+13.58%TONUSD+23.87%TAOUSDT+22.68%AAVEUSD+3.47%DOTUSDT+2.80%ICPUSDT+2.41%ONDOUSDT+0.32%ARBUSDT+1.16%WLDUSDT+2.72%JUPUSDT-1.71%ATOMUSDT+0.33%INJUSDT-1.68%STXUSDT+3.53%FETUSDT+14.36%SEIUSDT+13.34%TIAUSDT+4.80%PYTHUSDT+2.16%IMXUSDT+6.72%GRTUSDT+4.37%WIFUSDT+22.34%OPUSDT+0.34%IOTAUSDT-0.03%POLUSDT+0.64%FARTCOINUSDT+18.74%AXSUSDT+5.73%EOSUSDT+4.82%DYDXUSDT+4.40%ORDIUSDT+4.55%GALAUSDT+6.96%NOTUSDT+2.06%RONINUSDT+6.86%NVDA+0.02%AAPL-0.06%GOOGL+1.55%MSFT-0.07%AMZN+0.24%TSM+2.41%SPCX-0.56%META-0.07%AVGO+1.41%TSLA+0.07%SKHY+0.73%MU+0.08%LLY+1.00%BRK-B-1.52%AMD+9.95%JPM+0.68%WMT+0.67%V+0.45%XOM-3.20%ASMLa+2.45%JNJ-0.19%INTC+12.14%0700.HK+4.58%MA+0.43%ABBV+0.20%1398.HK-1.09%CSCO+1.78%ORCL+0.64%BAC+0.40%CVX-2.73%COST+0.35%DELL+1.26%LRCX+4.92%CAT+0.93%KO-1.28%AMAT+4.42%AP2d+5.60%0005.HK-0.10%HSBA.L+1.40%PG-0.19%ARM+17.16%UNH+0.18%GE+1.51%3988.HK-0.45%MS+1.75%1816.HK-30.02%NFLX+2.19%0939.HK-0.28%HD-0.93%0857.HK-0.63%NZDJPY+0.84%CHFJPY+0.63%NZDCAD+0.62%EURNZD-0.57%NZDMXN+0.53%USDJPY+0.50%GBPNZD-0.49%NZDSGD+0.43%AUDNZD-0.43%CADCHF-0.42%GBPTRY+0.41%AUDJPY+0.39%GBPJPY+0.32%EURCHF-0.32%GBPHKD+0.32%NZDUSD+0.31%NOKJPY+0.30%USDCAD+0.30%GBPCHF-0.29%GBPMXN-0.28%EURJPY+0.27%NZDCHF+0.23%EURUSD-0.22%AUDCHF-0.22%GBPZAR+0.19%SGDJPY+0.19%CADJPY+0.19%AUDCAD+0.19%USDZAR+0.18%GBPUSD-0.18%AUDNOK-0.18%EURZAR+0.16%USDILS+0.16%USDTHB-0.16%EURNOK-0.16%GBPCAD+0.13%CHFNOK-0.13%USDCHF-0.12%USDNOK-0.12%USDTRY+0.11%AUDUSD-0.11%USDPLN+0.09%EURAUD-0.09%USDMXN+0.09%PLNJPY+0.09%EURHKD-0.07%AUDSGD-0.07%GBPAUD-0.06%EURPLN+0.06%EURCNH+0.05%EURSGD-0.05%EURCZK+0.05%EURCAD+0.05%USDCOP-0.04%EURGBP-0.03%USDDKK+0.03%CHFSGD-0.03%USDHKD-0.03%EURSEK-0.02%USDCNH+0.02%USDSGD-0.02%AUDDKK-0.02%USDSEK+0.01%GBPSGD-0.01%EURDKK0.00%CHFSEK0.00%USOIL+1.53%UKOIL+1.51%XNGUSD+1.17%GAGUSD-1.10%XAGUSD-1.10%XPTUSD-1.10%XAUUSD-0.55%GAUUSD-0.55%COTTON-0.37%HG1+0.28%W1-0.17%S1-0.10%BTCUSD+5.32%ETHUSD+3.39%USDTUSD-0.04%XRPUSD+7.96%SOLUSD+4.89%TRXUSDT+1.93%ZECUSDT-0.42%DOGEUSD+14.65%XMRUSDT+2.69%LINKUSD+3.51%XLMUSD+7.81%UNIUSD+2.18%BCHUSDT+5.01%LTCUSD+3.89%HBARUSDT+7.44%SUIUSD+13.58%TONUSD+23.87%TAOUSDT+22.68%AAVEUSD+3.47%DOTUSDT+2.80%ICPUSDT+2.41%ONDOUSDT+0.32%ARBUSDT+1.16%WLDUSDT+2.72%JUPUSDT-1.71%ATOMUSDT+0.33%INJUSDT-1.68%STXUSDT+3.53%FETUSDT+14.36%SEIUSDT+13.34%TIAUSDT+4.80%PYTHUSDT+2.16%IMXUSDT+6.72%GRTUSDT+4.37%WIFUSDT+22.34%OPUSDT+0.34%IOTAUSDT-0.03%POLUSDT+0.64%FARTCOINUSDT+18.74%AXSUSDT+5.73%EOSUSDT+4.82%DYDXUSDT+4.40%ORDIUSDT+4.55%GALAUSDT+6.96%NOTUSDT+2.06%RONINUSDT+6.86%
AP

Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ • Healthcare

$20.16
+$1.44 (+7.7%)
Market closed

Last close at September 21, 2026 at 20:00 UTC

Open$19.97
Day Range$19.69 - $21.18
Avg. Volume (3M)2.2M
Market Cap$6.4B
P/E Ratio40.3
52 Week Range
$9.49$21.18
Next EarningsIn 37 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$796.1M100%
Gross Profitminus cost of goods$334.5M42%
Operating Incomeminus R&D and overhead$145.9M18%
Net Incomeminus taxes and the rest$57.6M7%

In plain terms: out of every $100 in revenue, Amneal Pharmaceuticals, Inc. keeps $7 as net profit.

Fundamentals & Financials

Revenue (TTM)
$3.1B
Net Income (TTM)
$157.3M
EPS (TTM)
$0.5
ROA (TTM)
4.17%
Current Ratio
2.2
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+16.7%Q1 2026$0.21
+58.8%Q2 2026$0.27
+34.8%Q3 2026$0.3
Next

Oct 29

in 37 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) develops, makes, and sells generic and branded medicines in the healthcare sector, with additional distribution of medical supplies and related services. Across its pharmaceutical manufacturing and supply businesses, Amneal generated $3.0 billion of revenue in FY2025.

Name
Amneal Pharmaceuticals, Inc.
CEO
Chirag K. Patel
Website
www.amneal.com
Industry
Healthcare
Year Founded
2002
Employees
8,700

Today's Snapshot

AI-generated

AMRX closed 7.8% higher at 20.16, in line with a firmer sector. Shares changed hands at roughly twice its usual level. Barclays, an investment bank, kept its positive rating on Amneal.

Trading Volume

Above 10d avg 2.9M

5.6M

vs S&P 500 Today

Strong Outperformance

+6.14%

Updated: September 21, 2026 at 20:23 UTC

Technical Indicators

6 Buy1 Neutral1 Sell
AMRX is trading around $20.16 and shows a strong bullish alignment: price is above short-, medium- and long-term moving averages, momentum measures and the MACD are positive, and on‑balance volume confirms buying interest even as some oscillators register overbought readings. Trend strength is moderate and volatility is contained, while the classic pivot sits well below the current level and provides upside confirmation. Technical takeaway: Strong Buy.
All signals
  • EMA (5 indicators)$14.86 - $18.19
    Buy
  • RSI (14)70.16
    Sell
  • Stochastic %K (14, 3, 3)75.21
    Neutral
  • MACD Level (12, 26)0.23
    Buy

Peers & Related Assets

LNTHLantheus Holdings, Inc.
$100.28-0.3%
MIRMMirum Pharmaceuticals, Inc.
$92+0.2%
INDVIndivior Pharmaceuticals Inc
$35.53+1.9%
NVSTEnvista Holdings Corp
$23.43+0.3%
DYNDyne Therapeutics, Inc.
$17.12+0.1%
SUPNSupernus Pharmaceuticals, Inc.
$42.78+1.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.